A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/16/2011	EP2386550A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
11/16/2011	EP2386547A1 Multicyclic amino acid derivatives and methods of their use
11/16/2011	EP2386546A1 Novel pyrazole-3-carboxamide derivate having 5-ht2b receptor antagonist activity
11/16/2011	EP2386545A1 Heteroaryl ureas containing nitrogen hetero-atoms as P38 kinase inhibitors
11/16/2011	EP2386543A1 3-Z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition
11/16/2011	EP2386542A1 Diindolylmethane and c-substituted diindolylmethane compositions and methods for the treatment of multiple cancers
11/16/2011	EP2386540A1 Novel compounds, their preparation and use
11/16/2011	EP2386539A2 Modified lysine-mimetic compounds
11/16/2011	EP2386319A1 Promoters exhibiting endothelial cell specificity and methods of using same
11/16/2011	EP2386317A1 Methods for treating conditions associated with MASP-2 dependent complement activation
11/16/2011	EP2386316A1 Methods for treating conditions associated with MASP-2 dependent complement activation
11/16/2011	EP2386315A1 Methods for treating conditions associated with MASP-2 dependent complement activation
11/16/2011	EP2386306A1 Pharmaceutical agent having long-lasting effect of treating arthritic disorders
11/16/2011	EP2386305A2 Selective Estrogen Receptor Modulator in Combination With Dehydroepiandrosterone (DHEA) or Analogues
11/16/2011	EP2386304A2 Selective Estrogen Receptor Modulator in Combination With Dehydroepiandrosterone (DHEA) or Analogues
11/16/2011	EP2386303A1 Eslicarbazepine acetate and methods of use
11/16/2011	EP2386302A1 A controlled release pharmaceutical dosage form of trimetazidine and processes for the preparation thereof
11/16/2011	EP2386301A1 Pharmaceutical composition of levoamlodipine or pharmaceutically acceptable salts thereof and blockers, and use thereof
11/16/2011	EP2386300A1 Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality in patients having a first recurrence of atrial fibrillation or atrial flutter
11/16/2011	EP2386299A2 1-Amino-Alkylcyclohexane derivatives for the treatment of cochlear tinnitus
11/16/2011	EP2386298A1 Treatment of intestinal conditions
11/16/2011	EP2386296A2 New application forms for cineol
11/16/2011	EP2386295A2 Tablets with site time-controlled gastrointestinal release of active ingredients
11/16/2011	EP2386294A2 Unitary pharmaceutical dosage form comprising Tenofovir DF
11/16/2011	EP2386291A1 Vaginally administrable progesterone-containing tablets and method for preparing same
11/16/2011	EP2386269A2 Naltrexone long acting formulations and methods of use
11/16/2011	EP2385989A1 Genetic variants useful for risk assessment of thyroid cancer
11/16/2011	EP2385951A2 Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections
11/16/2011	EP2385948A1 Fused thiazolo and oxazolo pyrimidinones
11/16/2011	EP2385946A1 Derivatives of 6-cycloamino-2,3-di-pyridinyl-imidazo[1,2-b]-pyridazine, preparation and tuerapeutic application thereof
11/16/2011	EP2385945A1 Triazolo and tetrazolo pyrimidine derivatives as hne inhibitors for treating copd
11/16/2011	EP2385943A2 Fluorine containing compounds and methods of use thereof
11/16/2011	EP2385942A1 Benzimidazole and pyrazolopyridine derivatives for treating and/or preventing cardiovascular diseases
11/16/2011	EP2385939A1 Dihydropyridone amides as p2x7 modulators
11/16/2011	EP2385935A1 Compounds and uses thereof for treating inflammation and modulating immune responses
11/16/2011	EP2385934A1 Inhibitors of phosphatidylinositol-3-kinase (pi3) and inducers of nitric oxide (no)
11/16/2011	EP2385833A1 Combination of a cyclosporine derivative and nucleosides for treating hcv
11/16/2011	EP2385832A1 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
11/16/2011	EP2385831A2 Small molecule inhibitors of nads, namnat, and nmnat
11/16/2011	EP2385830A1 Treatment of diabetes in patients with inadequate glycemic control despite metformin therapy comprising a dpp-iv inhibitor
11/16/2011	EP2385829A1 Pro-neurogenic compounds
11/16/2011	EP2385826A2 Methods and materials for delivering bile acids
11/16/2011	EP2385823A1 Dual release pharmaceutical suspension
11/16/2011	EP2385821A1 Improved pharmaceutical formulation
11/16/2011	EP2385763A1 Methods for treating vascular leak syndrome
11/16/2011	EP2385760A1 Inhibition of bacterial protein production by polyvalent oligonucleotide modified nanoparticle conjugates
11/16/2011	EP2385758A1 Tellurium-containing compounds for affecting female's reproductive system following chemotherapy and/or radiotherapy
11/16/2011	EP2385757A1 Tellurium-containing compounds for affecting male's fertility following chemotherapy and/or radiotherapy
11/16/2011	EP2285800B1 Quinoline or isoquinoline substituted p2x7 antagonists
11/16/2011	EP2225243B1 Derivatives of N-heterocyclic-6-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
11/16/2011	EP2209789B1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
11/16/2011	EP2170346B1 Treatment or prevention of hypertensive disorders of pregnancy or fetal growth retardation
11/16/2011	EP2142533B1 Imidazolidinone derivatives
11/16/2011	EP2139482B1 Treatment for multiple myeloma
11/16/2011	EP2134326B1 Pharmaceutical compositions comprising irbesartan
11/16/2011	EP2132216B1 Novel nucleoside analogs for treatment of viral infections
11/16/2011	EP2125785B1 Indole-3-yl-carbonyl-piperidine- derivatives for the treatment of anxiety and depressive disorders via v1a receptor antagonism
11/16/2011	EP2087897B1 Method for producing apyrogenic immunomodulator
11/16/2011	EP2086959B1 Substituted 2-imidazoles as modulators of the trace amine associated receptors
11/16/2011	EP2086552B1 Azithromycin for the treatment of nodular acne
11/16/2011	EP2069334B1 Aspalathin-like dihydrochalcone, extracts from unfermented rooibos and process for preparation
11/16/2011	EP2036555B1 The use of pyridone derivatives for preventing and treating radiation injury of lungs
11/16/2011	EP2027086B1 N-benzoyl-pyrrolidin-3-ylamines as histamine-3 antagonists
11/16/2011	EP2003130B1 Novel pyridine derivative having anti-helicobacter pylori activity
11/16/2011	EP1978973B1 Use hedgehog kinase antagonists to inhibit hedgehog signaling and to treat cancer
11/16/2011	EP1962826B1 Method for weight reduction
11/16/2011	EP1954287B1 Cetp inhibitors
11/16/2011	EP1948149B1 Formulation comprising metformin and vildagliptin
11/16/2011	EP1931676B1 Pyrazolopyrimidines as protein kinase inhibitors
11/16/2011	EP1924262B1 Methods and formulations for modulating lyn kinase activity and treating related disorders
11/16/2011	EP1901768B1 Methods of modulating il-23 activity; related reagents
11/16/2011	EP1899345B1 Pyrrolotriazine compounds useful as kinase inhibitors
11/16/2011	EP1899325B1 Imidazolinone and hydantoine derivatives as novel inhibitors of histone deacetylase
11/16/2011	EP1885722B1 Quinoline derivatives as ep4 antagonists
11/16/2011	EP1867673B1 Coordination compound composed of diaminocyclohexane platinum (ii) and block copolymer and anti-cancer agent comprising the same
11/16/2011	EP1855692B1 Compositions for treating skin diseases characterised by exudation of serum proteins
11/16/2011	EP1804780B1 Medium-chain length fatty alcohols as stimulators of hematopoiesis
11/16/2011	EP1784404B1 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof
11/16/2011	EP1746999B1 4-phenylamino-quinazolin-6-yl-amides
11/16/2011	EP1727794B1 Novel benzyl(idene)-lactam derivatives
11/16/2011	EP1696904B1 Use of rotigotine for the treatment or prevention of dopaminergic neurone loss
11/16/2011	EP1654285B1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
11/16/2011	EP1652533B1 Heart-slowing drug containing short-acting beta-blocker as the active ingredient
11/16/2011	EP1633368B1 Foamable pharmaceutical compositions and methods for treating a disorder
11/16/2011	EP1549327B1 Composition for treating hemorrhoids
11/16/2011	EP1542657B1 Cannabinoid liquid formulations for mucosal amdinistration
11/16/2011	EP1534340B1 Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto
11/16/2011	EP1506166B1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/16/2011	EP1487458B1 Multi-substituted selective androgen receptor modulators and methods of use thereof
11/16/2011	EP1455588B1 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis
11/16/2011	CN1938291B Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
11/16/2011	CN1931193B Medicine for treating various types of noxious sore, angiitis and stomatocace
11/16/2011	CN1930182B Antithrombotic compound
11/16/2011	CN1930160B Hiv integrase inhibitors
11/16/2011	CN1925846B Use of a 5-HT3 receptor antagonist for the manufacture of a medicament for the treatment of non-digestive tract derived abdominal disorders associated with pain
11/16/2011	CN1901906B Cci-779 for treating mantle cell lymphoma
11/16/2011	CN1777415B Medicinal composition containing edible acid or its acid salt and its use
11/16/2011	CN1757637B Method for purifying VE nicotinate raw material
11/16/2011	CN1706397B Composition of paeoniflorin and peony lactone glycoside with function of increasing leukocyte
11/16/2011	CN1650846B Elemene liposome and its preparation method

1 ... 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 ... 7860